Skip to main content
lexblog.com/lib/Y227B6HDviewrecordjson
{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "Louisiana Fourth Circuit Offers Clarification on the Role of Pharmaceutical Labeling and Package Inserts in Medical Malpractice Litigation: Deviation from manufacturer dosage instructions is not ipso facto evidence of breach",
    "url": "https://www.lexblog.com/2014/04/07/louisiana-fourth-circuit-offers-clarification-on-the-role-of-pharmaceutical-labeling-and-package-inserts-in-medical-malpractice-litigation-deviation-from-manufacturer-dosage-instructions-is-not-ipso/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-Y227B6HD",
        "url": "https://www.lexblog.com/lib/Y227B6HD/"
    },
    "datePublished": "2014-04-07T11:45:34-04:00",
    "dateModified": "2023-09-29T15:00:51-04:00",
    "author": {
        "@type": "Person",
        "name": "Karen Fontana Young"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Kean Miller"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Louisiana Law Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "http://louisianalawblog.wp.lexblogs.com/2014/04/louisiana-fourth-circuit-offers-clarification-on-the-role-of-pharmaceutical-labeling-and-package-inserts-in-medical-malpractice-litigation-deviation-from-manufacturer-dosage-instructions-is-not-ipso/",
    "sourceStability": "may-move"
}